The pathophysiological changes underlying impairment of cognition in Parkinson's disease (PD) are complex and not fully understood till date. Hence, understanding the structural changes responsible for cognitive decline in PD is essential for early diagnosis and to offer effective treatment. In this review, we discuss the neuroanatomical changes in major brain structures responsible for cognition in PD. We have included the key findings of various studies to provide up-to-date information for better understanding of pathophysiology of PD, which will help researchers and clinicians in planning and developing new treatment methods for the benefit of PD patients.
INTRODUCTION
Parkinson's disease (PD) is characterized by slowness of movement, rigidity, tremor, postural instability, and often cognitive impairments. [1] Although motor features are more prominent in PD, nonmotor features also have been diagnosed in PD patients. [2] Acetylcholine, norepinephrine, and serotonin may have a role in nonmotor features of PD. Features include cognitive impairment, psychological, autonomic, and sleep disorders which decrease the quality of life further. [3, 4] The pathophysiological changes underlying impairment of cognition in PD are complex and not fully understood till date. [5] Hence, understanding the structural changes responsible for cognitive decline in PD is essential for early diagnosis and to offer effective treatment. [6] [7] [8] In this review, we discuss the neuroanatomical changes in major brain structures responsible for cognition in PD.
C H A N G E S I N B A S A L G A N G L I A I N PARKINSON'S DISEASE
Since changes in the morphology of basal ganglia are noticed in bipolar and unipolar disorders also, it is essential to understand the changes in basal ganglia in PD for reliable diagnosis. Basal ganglia process the signals from the cortex for accurate execution of voluntary movements. [9] Basal ganglia play a key role in cognitive functions, [10] and lesion of basal ganglia causes impairment in cognitive functions. [11] In fact, basal ganglia are the most affected brain area in PD. [12] It was reported that there were two subtypes of PD and each type will affect basal ganglia in a different fashion. The subtypes include heterogeneous clinical phenotypes such as tremor dominant (TD) and postural instability/gait difficulty (PIGD). [13] PD patients had reduced fractional anisotropy within the substantia nigra and increased mean and radial diffusivity within the substantia nigra and globus pallidus. However, microstructural changes within the substantia nigra are severely affected in PIGD patients compared to TD. [14] Reduction of the neuromelanin pigmentation, neuronal loss, and Lewy bodies are observed in the substantia nigra. [15] In PD patients, basal ganglia undergo atrophy, which depends on severity and duration of the disease. [16] In PD patients, loss of attenuation and length of the dendritic spines of medium-sized spiny neurons located in the striatum has been reported. [17] Reduction in the volumes of the caudate nucleus and thalamus and white matter is observed in PD, which may be an early sign of disease progression. [18] 
CHANGES IN CEREBELLUM IN PARKINSON'S DISEASE
Increased activity of the cerebellum was observed during cognitive tasks. [19] The cerebellum has reciprocal connections with basal ganglia, and Parkinson's-related morphological changes were observed in animal models and humans. [20] These changes include significant contraction in the left cerebellum, decrease in the gray matter volume in the right quadrangular lobe. [21] These changes may be induced by degeneration of dopaminergic neurons [22] as the cerebellum receives dopaminergic projections from basal ganglia, and dopaminergic receptors were present in the cerebellum. [23] 
C H A N G E S I N B R A I N VO L U M E I N PARKINSON'S DISEASE
Strong correlation exists between brain size and cognitive functions. [24] In PD patients, atrophy of the brain was observed in many cortical and subcortical areas, which contributes in decrease in the volume of the brain. [25] Interestingly, it was reported that volume of the frontal lobe, temporoparietal junction, parietal lobe, insula, anterior cingulate cortex, basal ganglia, and thalamus increased in PD patients. [26] Prefrontal lobe plays a crucial role in cognitive functions and in PD patients; loss of gray matter has been reported. [27, 28] 
C H A N G E S I N T H A L A M U S I N PARKINSON'S DISEASE
Thalamic lesions are found to impair cognitive functions such as language, memory, and attention. [29] Thalamic stimulation was effective in enhancement of cognition through activation of neocortex and hippocampus and modulating gene expression. [30] Approximately 30%-40% loss was reported in the thalamus in PD. [31] It was reported that volume of the thalamus decreases in PD. [18] In contrast, it was reported that thalamic shape but not volume changes in PD. As specific nuclei of the thalamus are involved in PD, atrophy of the caudal intralaminar nucleus and hypertrophy of rest of the nucleus result in altered shape of the thalamus. [32] Further, changes in white matter of the mediodorsal thalamus lead to depression in most of the PD patients. [33] Significant reduction in fractional anisotropy was reported in anterior nucleus, dorsomedial nucleus, and ventral anterior nucleus of the thalamus. [34] 
C H A N G E S I N H Y P O T H A L A M U S I N PARKINSON'S DISEASE
Role of the hypothalamus in cognitive functions is well reported. [35] Impairment of hypothalamic function was reported in PD patients. Neural degeneration was observed in all 13 nuclei of the hypothalamus with predominant degeneration in tuberomamillary nucleus and the lateral and posterior hypothalamic nuclei. [36] Further, decrease in the levels of dopamine, serotonin, melanin, and hypocretin in the hypothalamus of PD patients. [37] Development of sleep, endocrine, and autonomic disorders in PD may be due to dopamine malfunction in the hypothalamus. [37] Sleep disorders may be due to loss of gray matter in hypothalamus as melatonin levels are associated with volume of gray matter. [38] As hypothalamus functioning is affected in PD, the secondary degeneration may occur to the structures directly innervated by the hypothalamus such as striatum where the dopamine synthesis occurs. [39] This further worsens the PD.
C H A N G E S I N L I M B I C S Y S T E M I N PARKINSON'S DISEASE
Influence of limbic structures on cognition was well documented. [40] Atrophy of gray matter was observed in Parkinson's patients with dementia. [41] Dopamine dysfunction in the limbic system leads to change in the creativity and emotional dysfunction in PD patients. [42] In amygdala, accessory cortical and central nuclei are affected more by PD, and cortical, accessory basal, and granular nuclei are least affected areas. [43] Posterior cingulum is the important structure in the papez circuit which is involved in processing of episodic memory. [44] It was reported that neuronal loss, gliosis, or demyelination in the white matter and metabolic changes occurs in the cingulum of PD patients. [44, 45] Change in the spontaneous resting-state neural activity is reported in prefrontal cortex, which was considered as a factor for cognitive decline in PD. [46] Further, regional atrophy in the hippocampus contributes to impaired verbal learning memory and visuospatial processing. [47] 
CHANGES IN LOCUS COERULEUS IN PARKINSON'S DISEASE
Loss of noradrenergic neuronal and Lewy bodies formation was much higher in locus coeruleus (LC) than dopaminergic neuronal loss in PD patients. Resting tremors of PD are due to neuronal loss of LC. [48, 49] About 35% of PD patients were depressed, and loss of noradrenergic pathways underlies the pathophysiology of depression in PD. [50] The pathological changes in LC of PD patients are peculiar and can be differentiated from changes that occur in other neurodegenerative diseases such as schizophrenia. [50] It was reported that simultaneous lesions of dopaminergic system, and LC causes metabolic dysfunction in the cerebral cortex and impairs cognitive functions in PD. [51] 
CHANGES IN GLIAL CELLS IN PARKINSON'S DISEASE
All glial cells can influence the cognitive functions. [52] Structural changes occur in astrocytes in response to physiological and pathological conditions may influence the neurons through nonsynaptic communication with neurons. [53] [54] [55] Altered neuroglial interaction may be the underlying cause for many neurological diseases including PD. [56] Glial response in PD offers both beneficial and hazardous effects. [57] 
CONCLUSION
In this review, we have presented the neuroanatomical changes of major brain structures related to cognition in PD. We have included the key findings of various studies to provide up-to-date information for better understanding of pathophysiology of PD, which helps researchers and clinicians in planning and developing new treatment methods for the benefit of PD patients.
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